-
1
-
-
33749459756
-
Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis.
-
Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med 2006: 130: 1466-1478.
-
(2006)
Arch Pathol Lab Med
, vol.130
, pp. 1466-1478
-
-
Miettinen, M.1
Lasota, J.2
-
2
-
-
15644363454
-
Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.
-
Hirota S, Isozaki K, Moriyama Y et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998: 279: 577-580.
-
(1998)
Science
, vol.279
, pp. 577-580
-
-
Hirota, S.1
Isozaki, K.2
Moriyama, Y.3
-
3
-
-
0242670019
-
PDGFRA activating mutations in gastrointestinal stromal tumors.
-
Heinrich MC, Corless CL, Duensing A et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003: 299: 708-710.
-
(2003)
Science
, vol.299
, pp. 708-710
-
-
Heinrich, M.C.1
Corless, C.L.2
Duensing, A.3
-
4
-
-
3042594995
-
The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status.
-
West RB, Corless CL, Chen X et al. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol 2004: 165: 107-113.
-
(2004)
Am J Pathol
, vol.165
, pp. 107-113
-
-
West, R.B.1
Corless, C.L.2
Chen, X.3
-
5
-
-
38649098794
-
A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors.
-
Espinosa I, Lee CH, Kim MK et al. A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. Am J Surg Pathol 2008: 32: 210-218.
-
(2008)
Am J Surg Pathol
, vol.32
, pp. 210-218
-
-
Espinosa, I.1
Lee, C.H.2
Kim, M.K.3
-
9
-
-
12144286747
-
Pleomorphic characteristics of a germ-line KIT mutation in a large kindred with gastrointestinal stromal tumors, hyperpigmentation, and dysphagia.
-
Robson ME, Glogowski E, Sommer G et al. Pleomorphic characteristics of a germ-line KIT mutation in a large kindred with gastrointestinal stromal tumors, hyperpigmentation, and dysphagia. Clin Cancer Res 2004: 10: 1250-1254.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 1250-1254
-
-
Robson, M.E.1
Glogowski, E.2
Sommer, G.3
-
10
-
-
0033678402
-
Germline-activating mutation in the kinase domain of KIT gene in familial gastrointestinal stromal tumors.
-
Isozaki K, Terris B, Belghiti J et al. Germline-activating mutation in the kinase domain of KIT gene in familial gastrointestinal stromal tumors. Am J Pathol 2000: 157: 1581-1585.
-
(2000)
Am J Pathol
, vol.157
, pp. 1581-1585
-
-
Isozaki, K.1
Terris, B.2
Belghiti, J.3
-
11
-
-
34548809741
-
Imatinib in the management of multiple gastrointestinal stromal tumors associated with a germline KIT K642E mutation.
-
Graham J, Debiec-Rychter M, Corless CL et al. Imatinib in the management of multiple gastrointestinal stromal tumors associated with a germline KIT K642E mutation. Arch Pathol Lab Med 2007: 131: 1393-1396.
-
(2007)
Arch Pathol Lab Med
, vol.131
, pp. 1393-1396
-
-
Graham, J.1
Debiec-Rychter, M.2
Corless, C.L.3
-
12
-
-
0036240932
-
Familial gastrointestinal stromal tumors associated with dysphagia and novel type germline mutation of KIT gene.
-
Hirota S, Nishida T, Isozaki K et al. Familial gastrointestinal stromal tumors associated with dysphagia and novel type germline mutation of KIT gene. Gastroenterology 2002: 122: 1493-1499.
-
(2002)
Gastroenterology
, vol.122
, pp. 1493-1499
-
-
Hirota, S.1
Nishida, T.2
Isozaki, K.3
-
13
-
-
24144503371
-
Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis.
-
Hartmann K, Wardelmann E, Ma Y et al. Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis. Gastroenterology 2005: 129: 1042-1046.
-
(2005)
Gastroenterology
, vol.129
, pp. 1042-1046
-
-
Hartmann, K.1
Wardelmann, E.2
Ma, Y.3
-
14
-
-
58649094197
-
Changes in the structure and function of ICC networks in ICC hyperplasia and gastrointestinal stromal tumors.
-
Kwon JG, Hwang SJ, Hennig GW et al. Changes in the structure and function of ICC networks in ICC hyperplasia and gastrointestinal stromal tumors. Gastroenterology 2009: 136: 630-639.
-
(2009)
Gastroenterology
, vol.136
, pp. 630-639
-
-
Kwon, J.G.1
Hwang, S.J.2
Hennig, G.W.3
-
15
-
-
0032420665
-
Neurofibromatosis 1 and piebaldism: a case report.
-
Tay YK. Neurofibromatosis 1 and piebaldism: a case report. Dermatology 1998: 197: 401-402.
-
(1998)
Dermatology
, vol.197
, pp. 401-402
-
-
Tay, Y.K.1
-
17
-
-
0025940323
-
Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism.
-
Giebel LB, Spritz RA. Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism. Proc Natl Acad Sci U S A 1991: 88: 8696-8699.
-
(1991)
Proc Natl Acad Sci U S A
, vol.88
, pp. 8696-8699
-
-
Giebel, L.B.1
Spritz, R.A.2
-
18
-
-
0028908831
-
Waardenburg syndrome type II: phenotypic findings and diagnostic criteria.
-
Liu XZ, Newton VE, Read AP. Waardenburg syndrome type II: phenotypic findings and diagnostic criteria. Am J Med Genet 1995: 55: 95-100.
-
(1995)
Am J Med Genet
, vol.55
, pp. 95-100
-
-
Liu, X.Z.1
Newton, V.E.2
Read, A.P.3
-
19
-
-
23044467277
-
A knock-in mouse model of gastrointestinal stromal tumor harboring kit K641E.
-
Rubin BP, Antonescu CR, Scott-Browne JP et al. A knock-in mouse model of gastrointestinal stromal tumor harboring kit K641E. Cancer Res 2005: 65: 6631-6639.
-
(2005)
Cancer Res
, vol.65
, pp. 6631-6639
-
-
Rubin, B.P.1
Antonescu, C.R.2
Scott-Browne, J.P.3
-
20
-
-
0034654307
-
Point mutation in kit receptor tyrosine kinase reveals essential roles for kit signaling in spermatogenesis and oogenesis without affecting other kit responses.
-
Kissel H, Timokhina I, Hardy MP et al. Point mutation in kit receptor tyrosine kinase reveals essential roles for kit signaling in spermatogenesis and oogenesis without affecting other kit responses. EMBO J 2000: 19: 1312-1326.
-
(2000)
EMBO J
, vol.19
, pp. 1312-1326
-
-
Kissel, H.1
Timokhina, I.2
Hardy, M.P.3
-
21
-
-
0029907089
-
Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1.
-
Piao X, Paulson R, van der Geer P et al. Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1. Proc Natl Acad Sci U S A 1996: 93: 14665-14669.
-
(1996)
Proc Natl Acad Sci U S A
, vol.93
, pp. 14665-14669
-
-
Piao, X.1
Paulson, R.2
van der Geer, P.3
-
22
-
-
30944435631
-
Differences in signaling pathways and expression level of the phosphoinositide phosphatase SHIP1 between two oncogenic mutants of the receptor tyrosine kinase KIT.
-
Vanderwinden JM, Wang D, Paternotte N et al. Differences in signaling pathways and expression level of the phosphoinositide phosphatase SHIP1 between two oncogenic mutants of the receptor tyrosine kinase KIT. Cell Signal 2006: 18: 661-669.
-
(2006)
Cell Signal
, vol.18
, pp. 661-669
-
-
Vanderwinden, J.M.1
Wang, D.2
Paternotte, N.3
-
23
-
-
2542520755
-
Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs)
-
Duensing A, Medeiros F, McConarty B et al. Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs). Oncogene 2004: 23: 3999-4006.
-
(2004)
Oncogene
, vol.23
, pp. 3999-4006
-
-
Duensing, A.1
Medeiros, F.2
McConarty, B.3
-
24
-
-
36749030022
-
KIT oncogenic signaling mechanisms in imatinib-resistant gastrointestinal stromal tumor: PI3-kinase/AKT is a crucial survival pathway.
-
Bauer S, Duensing A, Demetri GD et al. KIT oncogenic signaling mechanisms in imatinib-resistant gastrointestinal stromal tumor: PI3-kinase/AKT is a crucial survival pathway. Oncogene 2007: 26: 7560-7568.
-
(2007)
Oncogene
, vol.26
, pp. 7560-7568
-
-
Bauer, S.1
Duensing, A.2
Demetri, G.D.3
|